Researchers from the Baltimore-based Johns Hopkins Bloomberg School of Public Health in collaboration with the CDC analyzed national adverse drug event data from psychiatric medications in adult ED patients from 2009 to 2011.
Results showed nearly 20 percent of the 89,094 psychiatric ADE ED visits, or approximately 17,000, result in hospitalizations each year. About 50 percent of those hospitalizations involve patients between the ages of 19 years and 44 years.
Of the visits each year, the following medications were the cause:
Sedatives and anxiolytics: 30,707 visits (34.5 percent), or 3.6 ADE ED visits per 10,000 outpatient prescription visits
Antidepressants: 25,377 (28.5 percent), or 2.4 ADE ED visits per 10,000 outpatient prescription visits
Antipsychotics: 21,578 (24.2 percent), or 11.7 ADE ED visits per 10,000 outpatient prescription visits
Lithium salts: 3,620 (4.1 percent), or 16.4 ADE ED visits per 10,000 outpatient prescription visits
Stimulants: 2,779 (3.1 percent), or 2.9 ADE ED visits per 10,000 outpatient prescription visits
More articles on capacity management:
Nurses union says staffing levels unsafe at Tri-City ED
80% of physicians overextended, at capacity, survey shows
60% of seniors show malnutrition in ED visits
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
